Liver phosphorylase phosphatase

Summary

Recent progress in studies on the properties and regulation of liver phosphorylase phosphatase can be divided into four stages. First, isolation from multiple molecular forms of phosphorylase phosphatase, of a single form of catalytic subunit (Mr = 32 000-35 000) which is active toward phosphorylase a and also toward a variety of protein substrates phosphorylated by either cyclic AMP-dependent protein kinase or other protein kinases. This was achieved by rather drastic procedures such as treatment with 80% ethanol at room temperature, incubation with 6 M urea, freeze-thawing in the presence of 0.2 M mercaptoethanol, or digestion by trypsin. These treatments caused concomitantly large enhancement of phosphorylase phosphatase activity, and the hypothesis was proposed that an ‘inactive’ form of phosphorylase phosphatase existed as complexes of a catalytic subunit and inhibitory proteins. Second, it was discovered that liver and muscle extracts contain trypsin-labile proteins which, after heating at 90 °C, inhibited the catalytic subunit of phosphorylase phosphatase. Two types of protein inhibitors were identified: ‘inhibitor-I’ was phosphorylated and activated by cyclic AMP-dependent protein kinase, whereas ‘inhibitor-2’ was not phosphorylated. Although inhibitor-1 has been implicated in hormonal regulation of glycogen metabolism in skeletal muscle, a similar role of protein inhibitors in the regulation of phosphorylase phosphatase in the liver has not been demonstrated and the physiological role of the inhibitor is questionable.

Third, it has been demonstrated that liver phosphorylase phosphatase is reversibly inactivated and regulated by glutathione disulfide (GSSG) at the catalytic subunit level. Liver phosphorylase phosphatase contains, per mole of catalytic subunit, two sulfhydryl groups, one of which reacts with GSSG to form mixed disulfide with consequent inactivation of the enzyme. The inactivated enzyme can be reactivated by glutathione(GSH) or other sulfhydryl compounds through a reverse reaction. Injection of GSSG into the portal vein of rabbits caused a rapid increase in phosphorylase-a activity in the liver, suggesting that GSSG is involved in regulation of phosphorylase activity in vivo.

Finally, current evidence suggests that liver phosphorylase phosphatase exists in the native state in a high molecular weight form which consists of the catalytic subunit and other regulatory subunits. One such enzyme species could be a 260 000-dalton protein composed of three different types of subunit, termed α, β and γ, or a 160 000-dalton protein composed of α and β subunits. The a subunit (Mr = 35 000) appears to be identical to the multifunctional catalytic subunit, whereas the β (Mr = 69 000) and γ (Mr = 58 000) subunits are catalytically inactive but can modify the catalytic a subunit. It seems likely that the substrate specificity and catalytic activity of the α subunit is considerably altered when it is part of larger complexes with other regulatory subunits (β and γ). It has also been suggested that in addition to the native form of phosphorylase phosphatase, liver contains a considerably large amount of latent phosphorylase phosphatase, the catalytic activity of which could be revealed only by treatment with trypsin or ethanol.